Topics

Novartis, Microsoft ink 5-year AI alliance

05:00 EDT 2 Oct 2019 | BioPharmaDive

Personalizing eye disease treatments and improving CAR-T therapy manufacturing are first on an agenda the companies hope will help prove AI's utility in medicine.

Original Article: Novartis, Microsoft ink 5-year AI alliance

NEXT ARTICLE

More From BioPortfolio on "Novartis, Microsoft ink 5-year AI alliance"

Quick Search